LIVANOVA PLC (LIVN) Stock Price, Quote, News and Overview
NASDAQ:LIVN - Nasdaq - GB00BYMT0J19 - Common Stock - Currency: USD
LIVN Quote, Performance and Key Statistics
41.7
-7.8 (-15.76%)
The current stock price of LIVN is 41.7 USD. In the past month the price decreased by -15.81%. In the past year, price decreased by -24.51%.
LIVN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 29.08 | 235.57B | ||
| ISRG | INTUITIVE SURGICAL INC | 78.27 | 204.63B | ||
| SYK | STRYKER CORP | 32.02 | 148.79B | ||
| BSX | BOSTON SCIENTIFIC CORP | 40.13 | 148.44B | ||
| MDT | MEDTRONIC PLC | 16.94 | 116.02B | ||
| BDX | BECTON DICKINSON AND CO | 16.54 | 66.06B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.27 | 42.14B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.22 | 41.49B | ||
| IDXX | IDEXX LABORATORIES INC | 40.88 | 37.65B | ||
| RMD | RESMED INC | 26.72 | 34.69B | ||
| DXCM | DEXCOM INC | 53.53 | 34.50B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 18.31 | 25.12B |
Related stock screener links
About LIVN
Company Profile
LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. The firm designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the design, development, manufacture, marketing and selling of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula and other related accessories. The company includes the Essenz Perfusion System, the Company’s next-generation HLM with an embedded patient monitor for tailored patient care strategies. Neuromodulation segment is engaged in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). The ACS segment is engaged in the development, production, and sale of temporary life support products.
Company Info
LIVANOVA PLC
20 Eastbourne Terrace
London W2 6LG GB
CEO: Damien McDonald
Employees: 2900
Company Website: https://www.livanova.com/
Investor Relations: https://investor.livanova.com
Phone: 442033250662
LIVANOVA PLC / LIVN FAQ
What is the stock price of LIVANOVA PLC today?
The current stock price of LIVN is 41.7 USD. The price decreased by -15.76% in the last trading session.
What is the ticker symbol for LIVANOVA PLC stock?
The exchange symbol of LIVANOVA PLC is LIVN and it is listed on the Nasdaq exchange.
On which exchange is LIVN stock listed?
LIVN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for LIVANOVA PLC stock?
16 analysts have analysed LIVN and the average price target is 71.81 USD. This implies a price increase of 72.2% is expected in the next year compared to the current price of 41.7. Check the LIVANOVA PLC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is LIVANOVA PLC worth?
LIVANOVA PLC (LIVN) has a market capitalization of 2.26B USD. This makes LIVN a Mid Cap stock.
How many employees does LIVANOVA PLC have?
LIVANOVA PLC (LIVN) currently has 2900 employees.
What are the support and resistance levels for LIVANOVA PLC (LIVN) stock?
LIVANOVA PLC (LIVN) has a resistance level at 47.21. Check the full technical report for a detailed analysis of LIVN support and resistance levels.
Is LIVANOVA PLC (LIVN) expected to grow?
The Revenue of LIVANOVA PLC (LIVN) is expected to grow by 5.43% in the next year. Check the estimates tab for more information on the LIVN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy LIVANOVA PLC (LIVN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of LIVN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of LIVN, evaluating the profitability, health, valuation and growth aspects
- LIVANOVA PLC (LIVN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- LIVANOVA PLC (LIVN) Sales and EPS estimates to see what analysts future expectations are.
- LIVANOVA PLC (LIVN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- LIVANOVA PLC (LIVN) Insider and Institutional Ownership to learn about the owners and their transactions.
- LIVANOVA PLC (LIVN) Stock Chart to make your own analysis
- LIVANOVA PLC (LIVN) Latest news and press-releases to stay up to date.
Does LIVANOVA PLC (LIVN) stock pay dividends?
LIVN does not pay a dividend.
When does LIVANOVA PLC (LIVN) report earnings?
LIVANOVA PLC (LIVN) will report earnings on 2025-04-29, before the market open.
What is the Price/Earnings (PE) ratio of LIVANOVA PLC (LIVN)?
The PE ratio for LIVANOVA PLC (LIVN) is 12.37. This is based on the reported non-GAAP earnings per share of 3.37 and the current share price of 41.7 USD. Check the full fundamental report for a full analysis of the valuation metrics for LIVN.
What is the Short Interest ratio of LIVANOVA PLC (LIVN) stock?
The outstanding short interest for LIVANOVA PLC (LIVN) is 3.74% of its float. Check the ownership tab for more information on the LIVN short interest.
LIVN Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to LIVN. When comparing the yearly performance of all stocks, LIVN is a bad performer in the overall market: 84.88% of all stocks are doing better.
LIVN Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to LIVN. LIVN has an average financial health and profitability rating.
LIVN Financial Highlights
Over the last trailing twelve months LIVN reported a non-GAAP Earnings per Share(EPS) of 3.37. The EPS increased by 19.93% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.91% | ||
| ROA | 0.94% | ||
| ROE | 1.81% | ||
| Debt/Equity | 0.46 |
LIVN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to LIVN. The Buy consensus is the average rating of analysts ratings from 16 analysts.
For the next year, analysts expect an EPS growth of 9.91% and a revenue growth 5.43% for LIVN